TEBPP_Cover

Topics in Evidence-Based Pharmacy Practice is a continually updated collection of features and editorials that review, examine, and comment on the overload of information in the pharmacy field. Features are reviews of clinical trials, studies, and guidelines that examine the validity of approach, methodology, results, and recommendations, and make recommendations that can affect decision making. Editorials allow leading and emerging minds in the field express their opinion on the ever-changing world of pharmacy practice. Read more...

About the Editors

12/23/2016 2:39:58 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Is there a benefit for use of early vasopressin in patients with kidney failure during treatment of septic shock? Lia Merila, Pharm. D. Candidate, Dawn Havrda, Pharm. D., BCPS, FCCP
12/23/2016 2:39:58 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Dulaglutide Instead of Insulin Glargine in Type 2 Diabetes Patients Already on Metformin and Glimepiride Therapy Tatiana I. Wright, Candidate, Dawn Havrda, Pharm. D., BCPS, FCCP
12/19/2016 2:46:15 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Is More Always Better? Olanzapine Added to Standard Antiemetics for Highly Emetogenic Chemotherapy Jenna Snoga, PharmD, Bradi L. Frei, PharmD, BCPS, BCOP
12/19/2016 2:46:15 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Anticoagulation for Venous Thromboembolism in Patients with Malignancies: Tinzaparin vs. Warfarin Tsz "Tiffany" Chan, PharmD, Candidate; Dawn Havrda, PharmD, BCPS, FCCP
12/6/2016 1:30:44 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Is Liraglutide the New LEADER Among the GLP1 Agonists? Dania Segura, PharmD candidate, Dawn Havrda, PharmD, BCPS, FCCP
12/6/2016 1:30:44 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Alteplase and Acute Ischemic Stroke: Can We Get More With Less? Erin Deneen, PharmD candidate, Dawn Havrda, PharmD, FCCP, BCPS
11/17/2016 2:47:22 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC First-Line Therapy for Type 2 Diabetes—Metformin Wins Again Dawn Havrda, PharmD, FCCP, BCPS
11/17/2016 2:47:22 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC One Tablet Fits All? The First Pangenotypic Agent for HCV Treatment Jola Salavaci, PharmD Candidate 2017, Jennifer Andres, PharmD, BCPS
9/29/2016 3:04:38 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Can Fractures Be Predicted After Bisphosphonate Treatment? Laura L. Smith, Pharm.D., BCPS, FCCP, Dawn Havrda, PharmD, FCCP, BCPS
9/29/2016 3:04:38 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Do Bleeding Concerns Outweigh the Benefits of Anticoagulation Therapy in the Elderly? Dawn E. Havrda, Pharm.D., BCPS, FCCP
9/16/2016 1:25:04 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Do Bleeding Concerns Outweigh the Benefits of Anticoagulation Therapy in the Elderly? Dawn E. Havrda, Pharm.D., BCPS, FCCP
9/16/2016 1:25:04 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Pegfilgrastim Use and Bone Pain: A Cohort Study of Community-Based Cancer Patients Erin Deneen, PharmD candidate, Dawn Havrda, PharmD, FCCP, BCPS
9/16/2016 1:25:04 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Can fractures be predicted after bisphosphonate treatment? Laura L. Smith, Pharm.D. candidate, Dawn Havrda, Pharm.D., FCCP, BCPS
9/16/2016 1:25:04 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Choosing Between DPP-4 Inhibitor and Sulfonylurea for Diabetic Add-on Therapy to Metformin Gina Fu, PharmD candidate, Dawn Havrda, PharmD, FCCP, BCPS
7/11/2016 1:02:56 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Is It Time to Include Varenicline in Combination Smoking Cessation Treatment? Gina Fu, PharmD Candidate, Dawn Havrda, PharmD, FCCP, BCPS
7/11/2016 1:02:56 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Lowering Systolic Blood Pressure to 120 mmHg vs. 140 mmHg: The SPRINT Trial Sandy Lim, PharmD, Candidate, Dawn Havrda, PharmD FCCP, BCPS
6/27/2016 12:14:43 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC The Time Has Come: Treatment of HCV in Renal Impairment Peter Nikolos, PharmD Candidate 2017, Jennifer Andres, PharmD, BCPS
6/27/2016 12:14:43 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Oral Anticoagulants plus Aspirin in Atrial Fibrillation: To Combine or Not to Combine? Dawn Havrda, PharmD, FCCP, BCPS
6/27/2016 12:14:43 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC NSAID Use With Oral Anticoagulants: Does Bleeding Risk Increase in Venous Thromboembolism? Dawn Havrda, PharmD, FCCP, BCPS
6/27/2016 12:14:43 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC A Home Run for Empagliflozin: Jardiance Steps Up to the Plate for Cardiovascular Benefit in Type 2 Diabetes Dawn Havrda, PharmD, BCPS, FCCP
4/21/2016 2:17:13 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC A Heart Failure Game Changer? K. Diane Beavers, PharmD, BCPS, BCCCP, Audra Wilson, PharmD Candidate, Jeffrey Lalama, PharmD, BCPS
4/21/2016 2:17:13 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Is it CheckMate for Everolimus in ADVANCED RENAL CELL CARINOMA compared to Nivolumab? By: Sarah E. Hogan, PharmD Candidate, Bradi L. Frei, BCPS, BCOP, MSc
4/15/2016 1:49:28 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC Bivalirudin Use in Acute Coronary Syndromes: Safety Concerns Continue John Jeffrey Jones, PharmD Candidate, Jeffrey Lalama, PharmD, BCPS
3/2/2016 11:12:52 AM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC The Truth on the Non-Vitamin K Oral Anticoagulants (NOACs) in the Treatment of Venous Thromboembolism in Cancer Amanda L. Porter, PharmD
1/11/2016 5:05:38 PM | Topics in Evidence-Based Pharmacy Practice PHARMACY HOT TOPIC The Effect of Moderate Intensity Statin with or without Ezetimibe in Patients with Acute Coronary Syndrome – do nonstatins have a place in therapy? Avneet Sidhu, Pharm.D. Candidate, Dawn Havrda, Pharm.D., BCPS, FCCP

About the Editors

William D. Linn, PharmD

Founding Editor

William D. Linn, PharmD, is the Assistant Dean and Chair of the Department of Pharmacy Practice in the Feik School of Pharmacy at the University of the Incarnate Word. He is also the senior editor of Pharmacotherapy in Primary Care, and has served as a clinical specialist in primary care for over twenty years at the South Texas Veterans Health Care System.

Dawn Havrda, PharmD, FCCP, BCPS

Senior Editor

Dawn E. Havrda, Pharm.D., FCCP, BCPS is a Professor and Chair of the Department of Pharmacy Practice in the Bernard J. Dunn School of Pharmacy at Shenandoah University. She is also a clinical pharmacist at Amherst Family Practice where she cares for patients with diabetes, hypertension, cardiovascular disorders, and chronic anticoagulation, as well as provides medication therapy management and assists patients with Medicare Part D.

Nada Al-Qadheeb, PharmD, BCPS, FCCP

Editor

Dr. Al-Qadheeb is a clinical specialist in the Medical and Surgical intensive care unit at King Faisal Specialist Hospital and Research Center (KFSH&RC). She received a BS degree in pharmacy from King Saud University, Riyadh, Saudi Arabia and the Doctor of Pharmacy from University of Maryland, Baltimore. Dr. Al-Qadheeb completed a specialty residency in Critical Care from The Johns Hopkins Hospital, Baltimore. She is board certified in pharmacotherapy and a fellow of the American College of Chest Physicians. She is the recipient of the Dumez Lecture Award for superior professionalism in pharmacy from the University of Maryland, Baltimore. Dr. Al-Qadheeb has several national and international presentations. Her research interests focus on the areas of critical care and infectious diseases.